Symbion-EBOS a $6b group

NeW Zealand-based EBOS says it will now seek a listing on the Australian Stock Exchange after the finalisation of its acquisition of Symbion Pharmacy last Friday. The NZ$1.1b takeover sees the enlarged company with a total turnover of around NZ$6 billion, but EBOS md Mark Waller said: “looking forward the increased scale and complementary nature of both businesses can be expected to open up additional revenue opportunities and operational efficiencies". Pharmacy Daily – Read More.